56 related articles for article (PubMed ID: 20478276)
1. Tibia tumor-induced cancer pain involves spinal p38 mitogen-activated protein kinase activation via TLR4-dependent mechanisms.
Liu S; Yang J; Wang L; Jiang M; Qiu Q; Ma Z; Liu L; Li C; Ren C; Zhou J; Li W
Brain Res; 2010 Jul; 1346():213-23. PubMed ID: 20478276
[TBL] [Abstract][Full Text] [Related]
2. Sustained stimulation of β
Zhang X; Hartung JE; Bortsov AV; Kim S; O'Buckley SC; Kozlowski J; Nackley AG
Brain Behav Immun; 2018 Oct; 73():520-532. PubMed ID: 29935309
[TBL] [Abstract][Full Text] [Related]
3. Stage-dependent anti-allodynic effects of intrathecal Toll-like receptor 4 antagonists in a rat model of cancer induced bone pain.
Li X; Wang XW; Feng XM; Zhou WJ; Wang YQ; Mao-Ying QL
J Physiol Sci; 2013 May; 63(3):203-9. PubMed ID: 23392901
[TBL] [Abstract][Full Text] [Related]
4. Involvement of p38MAPK on the antinociceptive action of myricitrin in mice.
Meotti FC; Posser T; Missau FC; Pizzolatti MG; Leal RB; Santos AR
Biochem Pharmacol; 2007 Sep; 74(6):924-31. PubMed ID: 17678631
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of PDGF siRNA-mediated inhibition of bone cancer pain in the spinal cord.
Xu Y; Liu J; He M; Liu R; Belegu V; Dai P; Liu W; Wang W; Xia QJ; Shang FF; Luo CZ; Zhou X; Liu S; McDonald J; Liu J; Zuo YX; Liu F; Wang TH
Sci Rep; 2016 Jun; 6():27512. PubMed ID: 27282805
[TBL] [Abstract][Full Text] [Related]
6. Ketamine reduces the induced spinal p38 MAPK and pro-inflammatory cytokines in a neuropathic rats.
Kwon SY; Yeom JH; Joo JD
Korean J Anesthesiol; 2014 Jan; 66(1):52-8. PubMed ID: 24567814
[TBL] [Abstract][Full Text] [Related]
7. Tumor p38MAPK signaling enhances breast carcinoma vascularization and growth by promoting expression and deposition of pro-tumorigenic factors.
Limoge M; Safina A; Truskinovsky AM; Aljahdali I; Zonneville J; Gruevski A; Arteaga CL; Bakin AV
Oncotarget; 2017 Sep; 8(37):61969-61981. PubMed ID: 28977919
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Ionomic Profiles of Spinal Cords in a Rat Model with Bone Cancer Pain.
Huang J; Chen J; Ma L; Zhu X; Wan L; Li X; Guo C
J Pain Res; 2024; 17():1531-1545. PubMed ID: 38682106
[TBL] [Abstract][Full Text] [Related]
9. Animal Models of Cancer-Related Pain: Current Perspectives in Translation.
Pineda-Farias JB; Saloman JL; Scheff NN
Front Pharmacol; 2020; 11():610894. PubMed ID: 33381048
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain.
Kwilasz AJ; Green Fulgham SM; Duran-Malle JC; Schrama AEW; Mitten EH; Todd LS; Patel HP; Larson TA; Clements MA; Harris KM; Litwiler ST; Harvey LO; Maier SF; Chavez RA; Rice KC; Van Dam AM; Watkins LR
Brain Behav Immun; 2021 Mar; 93():80-95. PubMed ID: 33358978
[TBL] [Abstract][Full Text] [Related]
11. Down-Regulation of NOX4 Expression in Dorsal Horn of Spinal Cord Could Alleviate Cancer-Induced Bone Pain in Rats by Reducing Oxidative Stress Response.
Long H; Zheng H; Ai L; Osman K; Liu Z
Cancer Manag Res; 2020; 12():10929-10938. PubMed ID: 33154672
[TBL] [Abstract][Full Text] [Related]
12. B14 ameliorates bone cancer pain through downregulating spinal interleukin-1β via suppressing neuron JAK2/STAT3 pathway.
Xu M; Ni H; Xu L; Shen H; Deng H; Wang Y; Yao M
Mol Pain; 2019; 15():1744806919886498. PubMed ID: 31615322
[TBL] [Abstract][Full Text] [Related]
13. The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain.
Shenoy PA; Kuo A; Khan N; Gorham L; Nicholson JR; Corradini L; Vetter I; Smith MT
Front Pharmacol; 2018; 9():495. PubMed ID: 29867498
[TBL] [Abstract][Full Text] [Related]
14. Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone pain.
Liu L; Gao XJ; Ren CG; Hu JH; Liu XW; Zhang P; Zhang ZW; Fu ZJ
Exp Ther Med; 2017 Feb; 13(2):461-466. PubMed ID: 28352316
[TBL] [Abstract][Full Text] [Related]
15. P2Y
Liu M; Yao M; Wang H; Xu L; Zheng Y; Huang B; Ni H; Xu S; Zhou X; Lian Q
J Pain Res; 2017; 10():417-426. PubMed ID: 28243146
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Spinal CCR5/PKCγ Signaling Pathway in the Maintenance of Cancer-Induced Bone Pain.
Hang LH; Li SN; Dan X; Shu WW; Luo H; Shao DH
Neurochem Res; 2017 Feb; 42(2):563-571. PubMed ID: 27848062
[TBL] [Abstract][Full Text] [Related]
17. The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in Rats.
Shenoy PA; Kuo A; Vetter I; Smith MT
Front Pharmacol; 2016; 7():286. PubMed ID: 27630567
[TBL] [Abstract][Full Text] [Related]
18. SP, CGRP changes in pyridoxine induced neuropathic dogs with nerve growth factor gene therapy.
Kang JY; Yoo DY; Lee KY; Im W; Kim M; Choi JH; Youn HY; Kim SH; Hwang IK; Chung JY
BMC Neurosci; 2016 Jan; 17():1. PubMed ID: 26728069
[TBL] [Abstract][Full Text] [Related]
19. Sigma-1 Receptor Antagonist BD1047 Reduces Mechanical Allodynia in a Rat Model of Bone Cancer Pain through the Inhibition of Spinal NR1 Phosphorylation and Microglia Activation.
Zhu S; Wang C; Han Y; Song C; Hu X; Liu Y
Mediators Inflamm; 2015; 2015():265056. PubMed ID: 26696751
[TBL] [Abstract][Full Text] [Related]
20. Use of Animal Models in Understanding Cancer-induced Bone Pain.
Slosky LM; Largent-Milnes TM; Vanderah TW
Cancer Growth Metastasis; 2015; 8(Suppl 1):47-62. PubMed ID: 26339191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
